LWP
WST icon

Lumature Wealth Partners’s West Pharmaceutical WST Stock Holding History

Lumature Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$279K Sell
730
-21
-3% -$7.5K 0.17% 120
2023
Q1 		$260K Buy
751
+1
+0.1% +$292 0.15% 123
2022
Q4 		$177K Sell
750
-33
-4% -$7.82K 0.1% 156
2022
Q3 		$193K Buy
783
+48
+7% +$14.6K 0.1% 158
2022
Q2 		$222K Buy
735
+151
+26% +$49.1K 0.1% 155
2022
Q1 		$240K Buy
+584
New +$229K 0.1% 151

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Lumature Wealth Partners's WST Position: Q2 2023 in Review

Lumature Wealth Partners reduced its West Pharmaceutical (WST) stake by 2.8% in Q2 2023, selling an estimated $7.5K and leaving 730 shares worth $279K. The position accounts for 0.17% of the portfolio, ranked #120.

Lumature Wealth Partners first reported a position in WST in Q1 2022 and has held it in 6 quarters since. 735 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • Lumature Wealth Partners held 730 shares of West Pharmaceutical worth $279K as of Q2 2023.
  • Lumature Wealth Partners sold 21 West Pharmaceutical shares in Q2 2023, an estimated $7.5K.
  • West Pharmaceutical made up 0.17% of Lumature Wealth Partners's portfolio in Q2 2023, its #120 holding.
  • Lumature Wealth Partners first reported a position in West Pharmaceutical in Q1 2022 and has held it in 6 quarters since.
  • 735 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.